Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Atkinson

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinomaM E Gordinier, H Z Zhang, R Patenia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 1997
DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasiaI V Boiko, M F Mitchell, D K Pandey, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 12, 2001
Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years laterC F Verschraegen, M Benjapibal, W Supakarapongkul, et al.
Cancer|December 11, 1999
A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinomaD M Gershenson, M Morris, T W Burke, et al.
Anticancer Research|July 23, 1998
Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patientsT Levy, I Agoulnik, E N Atkinson, et al.
Lung Cancer (Amsterdam, Netherlands)|October 29, 1998
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerJ A Roth, E N Atkinson, F Fossella, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
New tumor markers: CA125 and beyondR C Bast, D Badgwell, Z Lu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2004
A pilot study for a screening trial of cervical fluorescence spectroscopyA Nath, K Rivoire, S Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomaR S Freedman, A P Kudelka, J J Kavanagh, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinomaM E Gordinier, H Z Zhang, R Patenia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 1997
DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasiaI V Boiko, M F Mitchell, D K Pandey, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 12, 2001
Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years laterC F Verschraegen, M Benjapibal, W Supakarapongkul, et al.
Cancer|December 11, 1999
A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinomaD M Gershenson, M Morris, T W Burke, et al.
Anticancer Research|July 23, 1998
Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patientsT Levy, I Agoulnik, E N Atkinson, et al.
Lung Cancer (Amsterdam, Netherlands)|October 29, 1998
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerJ A Roth, E N Atkinson, F Fossella, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
New tumor markers: CA125 and beyondR C Bast, D Badgwell, Z Lu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2004
A pilot study for a screening trial of cervical fluorescence spectroscopyA Nath, K Rivoire, S Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomaR S Freedman, A P Kudelka, J J Kavanagh, et al.
Pageof 8